Clinical Trials
27 trialsFONTANA
AstraZeneca
A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea
Novartis
Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
HARMONIC
Lantern Pharma Inc.
Shared Decision Making in Patients With Lung Cancer
Sichuan Cancer Hospital and Research Institute
Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma
Samsung Medical Center
Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm
Shanghai Pulmonary Hospital, Shanghai, China
Pathogenic Variants in Genes Associated With Lung Adenocarcinoma
Instituto Nacional de Cancerologia de Mexico
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Pfizer
Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer
Emory University
Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases
Sun Yat-sen University
Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute
KETO-FDG Lung
Fondazione del Piemonte per l'Oncologia
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients
Fu Jen Catholic University
EVLC
Palo Alto Veterans Institute for Research
Partial Tumor Irradiation and Immunotherapy for Unresectable Lung Cancer
Karl Landsteiner University of Health Sciences
BLCIO
Ohio State University Comprehensive Cancer Center
Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma
Jonsson Comprehensive Cancer Center
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Tizona Therapeutics, Inc
CRYOMUNE
Institut Bergonié
Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors
Tango Therapeutics, Inc.
An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer
Jonsson Comprehensive Cancer Center
MOv19-BBz CAR T Cells in FRa+ Cancers
University of Pennsylvania
RESET
Stony Brook University
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
Masonic Cancer Center, University of Minnesota